Gore wins FDA nod for deep venous stent

W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

The company touts Viabahn Fortegra as the first device for the treatment of deep venous disease in the inferior vena cava (IVC), iliac and iliofemoral veins. It marks the latest addition to the Viabahn device family, engineered to treat patients with deep venous disease.

Viabahn Fortegra features an open-structure, self-expanding, wire-wound nitinol frame and an expanded polytetrafluoroethylene (ePTFE) polymer lattice. Gore designed it for comfortability, strength and fracture resistance. The company says its novel technology helps to provide an optimal balance. It allows the stent to conform to the natural anatomy while providing compression resistance throughout the entire device.

Sign up for Blog Updates